Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Anti-VEGF treatment for choroidal neovascularization complicating pattern dystrophy-like deposit associated with pseudoxanthoma elasticum.

Battaglia Parodi M, Romano F, Marchese A, Arrigo A, Llorenç V, Cicinelli MV, Bandello F, Adán A.

Graefes Arch Clin Exp Ophthalmol. 2018 Nov 23. doi: 10.1007/s00417-018-4190-7. [Epub ahead of print]

PMID:
30470876
2.

Antituberculous Treatment Itself Might Prevent Visual Impairment in Presumed Tuberculosis-Related Uveitis.

Llorenç V, Benejam G, Mesquida M, Sainz de la Maza M, Molins B, Alba C, Pelegrin L, Martínez JA, Adán A.

Ocul Immunol Inflamm. 2018 Nov 5:1-8. doi: 10.1080/09273948.2018.1541326. [Epub ahead of print]

PMID:
30395738
3.

Bilateral Acute Retinal Necrosis: Clinical Features and Outcomes in a Multicenter Study.

Miserocchi E, Iuliano L, Fogliato G, Modorati G, Couto C, Schlaen A, Hurtado E, Llorenç V, Adan A, Bandello F.

Ocul Immunol Inflamm. 2018 Jul 30:1-9. doi: 10.1080/09273948.2018.1501494. [Epub ahead of print]

PMID:
30059636
4.

Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study.

Berasategui B, Fonollosa A, Artaraz J, Ruiz-Arruza I, Ríos J, Matas J, Llorenç V, Diaz-Valle D, Sastre-Ibañez M, Arriola-Villalobos P, Adan A.

BMC Ophthalmol. 2018 Jul 20;18(1):179. doi: 10.1186/s12886-018-0848-5.

5.

Reply.

Mesquida M, Llorenc V, Adan A.

Med Clin (Barc). 2018 Oct 23;151(8):336-337. doi: 10.1016/j.medcli.2018.02.005. Epub 2018 Mar 7. English, Spanish. No abstract available.

PMID:
29525112
6.

Targeting interleukin-6 in autoimmune uveitis.

Mesquida M, Molins B, Llorenç V, de la Maza MS, Adán A.

Autoimmun Rev. 2017 Oct;16(10):1079-1089. doi: 10.1016/j.autrev.2017.08.002. Epub 2017 Aug 2. Review.

PMID:
28778705
7.

TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA.

Mesquida M, Molins B, Llorenç V, Hernández MV, Espinosa G, Sainz de la Maza M, Adán A.

Retina. 2018 Jul;38(7):1361-1370. doi: 10.1097/IAE.0000000000001690.

PMID:
28520640
8.

Characterization of isolated retinal vasculitis. Analysis of a cohort from a single center and literature review.

Pelegrín L, Hernández-Rodríguez J, Espinosa G, Llorenç V, Sainz-de-la-Maza M, Fontenla JR, Martínez JA, Cid MC, Adán A.

Autoimmun Rev. 2017 Mar;16(3):237-243. doi: 10.1016/j.autrev.2017.01.006. Epub 2017 Jan 27. Review.

PMID:
28137481
9.

Bacillus Calmette-Guérin Infection and Cytotoxicity in the Retinal Pigment Epithelium.

Llorenç V, Mesquida M, Molins B, González-Martín J, Sainz de la Maza M, Adán A.

Ocul Immunol Inflamm. 2018;26(5):786-792. doi: 10.1080/09273948.2016.1265655. Epub 2016 Dec 23.

PMID:
28010156
10.

C-reactive protein isoforms differentially affect outer blood-retinal barrier integrity and function.

Molins B, Pascual A, Méndez, Llorenç V, Zarranz-Ventura J, Mesquida M, Adán A, Martorell J.

Am J Physiol Cell Physiol. 2017 Mar 1;312(3):C244-C253. doi: 10.1152/ajpcell.00057.2016. Epub 2016 Dec 21.

11.

New insights into the genetic component of non-infectious uveitis through an Immunochip strategy.

Márquez A, Cordero-Coma M, Martín-Villa JM, Gorroño-Echebarría MB, Blanco R, Díaz Valle D, Del Rio MJ, Blanco A, Olea JL, Cordero Y, Capella MJ, Díaz-Llopis M, Ortego-Centeno N, Ruiz-Arruza I, Llorenç V, Adán A, Fonollosa A, Ten Berge J, Atan D, Dick AD, De Boer JH, Kuiper J, Rothova A, Martín J.

J Med Genet. 2017 Jan;54(1):38-46. doi: 10.1136/jmedgenet-2016-104144. Epub 2016 Sep 8.

PMID:
27609017
12.

SAFETY AND EFFICACY OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN THE MANAGEMENT OF MACULAR EDEMA SECONDARY TO INFECTIOUS UVEITIS.

Fonollosa A, Llorenç V, Artaraz J, Jimenez B, Ruiz-Arruza I, Agirrebengoa K, Cordero-Coma M, Costales-Mier F, Adan A.

Retina. 2016 Sep;36(9):1778-85. doi: 10.1097/IAE.0000000000001001.

PMID:
27183031
13.

In Response to: "Deuter CM, Zierhut M, Igney-Oertel A, et al. Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment".

Mesquida M, Llorenç V, Adán A.

Ocul Immunol Inflamm. 2017 Apr;25(2):221-222. doi: 10.3109/09273948.2016.1145240. Epub 2016 Mar 25. No abstract available.

PMID:
27014943
14.

Interleukin-22 serum levels are elevated in active scleritis.

Sainz-de-la-Maza M, Molins B, Mesquida M, Llorenç V, Zarranz-Ventura J, Sala-Puigdollers A, Matas J, Adan A, Foster CS.

Acta Ophthalmol. 2016 Sep;94(6):e395-9. doi: 10.1111/aos.13005. Epub 2016 Mar 24.

15.

Elevated Serum Immune Mediators and Subclinical Inflammation in HLA-A29-associated Birdshot Chorioretinopathy.

Molins B, Mesquida M, Llorenç V, Sainz de la Maza M, Adán A.

Ocul Immunol Inflamm. 2016 Dec;24(6):647-652. Epub 2015 Dec 8.

PMID:
26645126
16.

Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization.

Llorenç V, Mesquida M, Sainz de la Maza M, Keller J, Molins B, Espinosa G, Hernandez MV, Gonzalez-Martín J, Adán A.

Acta Ophthalmol. 2015 Sep;93(6):561-7. doi: 10.1111/aos.12675. Epub 2015 Feb 15.

17.

Specific association of IL17A genetic variants with panuveitis.

Mucientes A, Márquez A, Cordero-Coma M, Martín-Villa JM, Gorroño-Echebarría MB, Blanco R, Díaz Valle D, Benítez-del-Castillo JM, del Rio MJ, Blanco A, Olea JL, Cordero Y, Capella MJ, Gonzalez J, Díaz-Llopis M, Ortego-Centeno N, Adán A, Ruiz-Arruza I, Llorenç V, Fonollosa A, Martín J.

Br J Ophthalmol. 2015 Apr;99(4):566-70. doi: 10.1136/bjophthalmol-2014-306106. Epub 2015 Jan 16.

PMID:
25595174
18.

Regulatory T cell levels and cytokine production in active non-infectious uveitis: in-vitro effects of pharmacological treatment.

Molins B, Mesquida M, Lee RW, Llorenç V, Pelegrín L, Adán A.

Clin Exp Immunol. 2015 Mar;179(3):529-38. doi: 10.1111/cei.12479.

19.

Certolizumab Pegol, a New Anti-TNF-α in the Armamentarium against Ocular Inflammation.

Llorenç V, Mesquida M, Sainz de la Maza M, Blanco R, Calvo V, Maíz O, Blanco A, de Dios-Jiménez de Aberásturi JR, Adán A.

Ocul Immunol Inflamm. 2016;24(2):167-72. doi: 10.3109/09273948.2014.967779. Epub 2014 Oct 17.

PMID:
25325834
20.

Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema.

Mesquida M, Molins B, Llorenç V, Sainz de la Maza M, Adán A.

Ophthalmology. 2014 Dec;121(12):2380-6. doi: 10.1016/j.ophtha.2014.06.050. Epub 2014 Sep 6.

PMID:
25204610

Supplemental Content

Loading ...
Support Center